Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 3
2001 5
2002 2
2003 3
2004 5
2005 4
2006 6
2007 7
2008 5
2009 3
2010 3
2011 5
2012 3
2013 3
2014 3
2015 5
2016 3
2017 2
2018 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Thalidomide in multiple myeloma.
Moehler TM, Hillengass J, Glasmacher A, Goldschmidt H. Moehler TM, et al. Curr Pharm Biotechnol. 2006 Dec;7(6):431-40. doi: 10.2174/138920106779116919. Curr Pharm Biotechnol. 2006. PMID: 17168659 Review.
Angiogenesis in hematologic malignancies.
Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Moehler TM, et al. Crit Rev Oncol Hematol. 2003 Mar;45(3):227-44. doi: 10.1016/s1040-8428(02)00135-x. Crit Rev Oncol Hematol. 2003. PMID: 12633837 Review.
Therapy of relapsed and refractory multiple myeloma.
Moehler T, Goldschmidt H. Moehler T, et al. Recent Results Cancer Res. 2011;183:239-71. doi: 10.1007/978-3-540-85772-3_11. Recent Results Cancer Res. 2011. PMID: 21509688 Review.
Angiogenesis in hematologic malignancies.
Moehler TM, Neben K, Ho AD, Goldschmidt H. Moehler TM, et al. Ann Hematol. 2001 Dec;80(12):695-705. doi: 10.1007/s00277-001-0398-3. Epub 2001 Nov 14. Ann Hematol. 2001. PMID: 11797109 Review.
Where is the primary tumour?
Zechmann CM, Giesel FL, Hillengass J, Mehndiratta A, Neben K, Delorme S, Moehler T. Zechmann CM, et al. Among authors: moehler t. Lancet. 2007 Nov 24;370(9601):1800. doi: 10.1016/S0140-6736(07)61747-4. Lancet. 2007. PMID: 18037083 No abstract available.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page